Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FQ95X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,000
Award facts
- Contract value 100% obligated
- $11,000.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Xeljanz XR 11 mg tablets in 30-unit packages. The contract, valued at $11,000.28, is a firm fixed-price delivery order with an ultimate completion date of November 13, 2025, and was competitively awarded without set-aside provisions. Performance will take place at the vendor's corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen's federal contract portfolio demonstrates significant capability in supplying critical pharmaceuticals and medical supplies to Department of Defense and veteran healthcare systems. The company's IDC with DLA encompasses a broad range of therapeutic products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The current award for Xeljanz XR—a prescription medication used in rheumatologic and other immune-mediated conditions—reflects the vendor's ongoing role as a key pharmaceutical provider supporting military and federal healthcare procurement needs.
Quick answers
Who was awarded contract SPE2DR26FQ95X?
SPE2DR26FQ95X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FQ95X worth?
The government has obligated $11,000 on SPE2DR26FQ95X.
Is contract SPE2DR26FQ95X an order under another contract?
Yes. SPE2DR26FQ95X is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FQ95X competed?
The extent of competition for SPE2DR26FQ95X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award